UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Understanding when to focus on short-term versus long-term investments can greatly impact your financial strategy. This guide helps you make informed decisions.
27,724 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Regulators signal a push on Regulation X changes and a new GSE streamline refi pathway, as LO Comp revisions lose mom...
Solana’s network momentum is rising in early 2026, yet a persistent FTX estate overhang and waning ETF inflows keep t...
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...
Super Micro Computer jumped 5% after posting a margin beat and raised guidance. The move fans the debate over a poten...
A new wave of tech IPOs is poised to influence index funds and passive strategies. Learn what it means for your portf...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Bitcoin faces a pivotal moment as a btc’s hidden liquidity cluster near crucial price blocks could dictate the next l...
IonQ and D-Wave fell more than 5% last week as investors tempered bets on quantum stocks amid broader market strength...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
Bitcoin remains rangebound near the mid-$60,000s as geopolitical tensions rise and expectations for policy easing fad...
XRP remains pressured across its major trading pairs as sellers dominate the backdrop. A sub-$1 test looms if support...